Oral GLP-1 Comparison Orforglipron vs Rybelsus: How Lilly’s Oral GLP-1 Pill Compares Orforglipron and Rybelsus are both once-daily oral GLP-1 receptor agonists, but they are not the same type of drug or used in the same way. Orforglipron is Lilly’s
Oral GLP-1 Weight-Loss Medication Orforglipron for Weight Loss: Results, Side Effects, and Current Status Orforglipron is an oral GLP-1 receptor agonist approved by the FDA under the brand name Foundayo for chronic weight management in adults with obesity, or adults
FDA Status & Drug Availability Is Retatrutide Approved Yet? FDA Status, Availability, and Timeline No. As of May 19, 2026, retatrutide is not FDA-approved for weight loss, type 2 diabetes, or any other condition. It remains an investigational once-weekly triple
Investigational Weight-Loss Drugs CT-388 for Weight Loss: Results, Side Effects, and Current Status CT-388, also called enicepatide, is an investigational once-weekly injectable GLP-1/GIP receptor agonist being developed by Roche and Genentech for obesity, type 2 diabetes, and related metabolic conditions.
Skin Peptides & Cosmetic Actives GHK-Cu Copper Peptide: The Complete 2026 Guide to Benefits, Science & Best Skincare Serums GHK-Cu, also called copper tripeptide-1, is a copper-binding peptide used in skincare for firmness, texture, fine lines, and skin repair support.
Drug Comparison CT-388 vs Tirzepatide: How Roche’s GLP-1/GIP Drug Compares CT-388 and tirzepatide are both once-weekly injectable GLP-1/GIP receptor agonists, but they are not at the same evidence stage. Tirzepatide is FDA-approved for chronic weight management under the Zepbound brand,
Investigational Weight-Loss Drugs VK2735 for Weight Loss: Oral GLP-1/GIP Results and Current Status VK2735 is an investigational dual GLP-1/GIP receptor agonist being studied for weight loss in both oral and injectable forms. The oral tablet has shown meaningful short-term weight
Investigational monthly weight-loss injection guide By VerifiedSupps Editorial Team MariTide for Weight Loss: Monthly Injection, Results, and Current Status MariTide is an investigational long-acting weight-loss medication designed for monthly or less frequent injection. In Phase 2, it produced substantial weight
GLP-1 plus glucagon weight-loss medication guide By VerifiedSupps Editorial Team Mazdutide for Weight Loss: Results, Side Effects, and How It Works Mazdutide is a once-weekly GLP-1/glucagon dual receptor agonist that has shown meaningful weight-loss results in Chinese clinical trials. It
Investigational GLP-1 plus glucagon liver and weight-loss guide By VerifiedSupps Editorial Team Pemvidutide for Weight Loss and Fatty Liver: Results, Side Effects, and Current Status Pemvidutide is an investigational once-weekly injectable GLP-1/glucagon dual receptor agonist being studied for obesity, metabolic